CTRI/2025/04/084023尚未招募Phase 3 4
Anatomical consideration of Hridaya(Anahata) chakra and its applied anatomy with special reference to Stage 1 Hypertension and cardiac electrical parameters
Institute of Medical Science, Banaras Hindu University1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2025年4月12日最近更新:
试验速览
- 阶段
- Phase 3 4
- 状态
- 尚未招募
- 发起方
- 入组人数
- 140
- 试验地点
- 1
- 主要终点
- Systolic and diastolic blood pressure
研究概览
简要总结
140 cases of Stage 1 Hypertension will be included in the interventional study which will be randomly divided into 4 groups of 35 patients in each group. First group will be the control group prescribed with Telmisartan 20mg. Second group will be prescribed with Telmisartan 20mg along with Sheetali pranayama and Yoganidra. Third group will be prescribed with Sarpagandha ghanvati 250 mg twice daily. Fourth group will be prescribed with Sarpagandha ghanvati 250 mg twice daily along with Sheetali pranayama and Yoganidra. It is expected that Sheetali pranayama and Yoganidra will reduce blood pressure in patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 40.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Willing to give consent to participate in the study.
- •Patients in age group between 40-60 years of either sex irrespective of religion, socio- economic status and occupation.
- •Patients having Grade1 Hypertension (SBP= 140-159mmHg & DBP= 90-99mmHg).
排除标准
- •Patients age less than 40 or greater than 60 years.
- •Patients with less than 140/90 mmHg and greater than 159/99 mmHg blood pressure.
- •Patients with Diabetes Mellitus, thyroid disorders.
- •Patients on steroid medicines or having Peptic ulcer.
- •Subjects who are pregnant and lactating.
- •Patients with habits of smoking and alcoholism.
- •Subjects who are with chronic illness except metabolic syndromes.
- •or hearing impairment.
- •Subjects who are taking any kind of sedatives or psychological treatments.
- •Subjects who are having other renal, hepatic, cardiovascular or respiratory disorders (such as asthma, bronchitis, or excessive mucus).
结局指标
主要结局
Systolic and diastolic blood pressure
时间窗: 3 months with follow up at 1 month interval
次要结局
- BMI(RFT)
研究者
Dr Gayathri R
Banaras Hindu University
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
Managing the primary hypertension in adults with individualized dynamized homoeopathic medicine - A prospective studyCTRI/2025/09/094729Sainath Homoeopathic Hospital50
尚未招募
不适用
Effect of equi-ratio breathing on heart and lung health in primary hypertension.CTRI/2025/03/081736Dr Abhishek poojari78
尚未招募
3 期
Anti hypertensive activity of polyherbal formulationCTRI/2025/01/079691BVG life sciences Limited60
尚未招募
2/3 期
A study to see how effective two herbal oil treatments are (Kumari Siddha Taila and Shatpushpa Siddha Taila) when used as enemas for helping women with PCOS who arent ovulating.CTRI/2025/07/090732Tilak ayurvedic mahavidyalaya rasta peth Pune50
尚未招募
2/3 期
A Comparative Study Of Efficacy Of Chaturbeej Churna With Latakaranj Churna In The Management Of Garbhashay ShodhanCTRI/2024/10/076031Tilak Ayurved Mahavidyalay50